Evidence map›Paper›PMID 39430885›Full record

ArticleLancet regional health. Americas2024

Transition towards cancer mortality predominance over cardiovascular disease mortality in Brazil, 2000-2019: a population-based study.

Beatriz Rache, Rudi Rocha, Luciana Alves de Medeiros, Letícia Martins Okada, Gerson Ferrari, Hongmei Zeng, Alessandro Bigoni, Maria Paula Curado, Catarina M Azeredo, Leandro F M Rezende

Abstract read
In one paragraph

Article in Lancet regional health. Americas, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Noncommunicable chronic diseases and health challenges in 2050.Revista brasileira de epidemiologia = Brazilian journal of epidemiology · 2026
    Article
  7. Revista de saude publica · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Beatriz RacheUniversity of California, Los Angeles (UCLA), Anderson School of Management, Los Angeles, CA, USA.
Rudi RochaInstituto de Estudos para Políticas de Saúde, São Paulo, SP, Brazil.
Luciana Alves de MedeirosFaculdade de Medicina, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.
Letícia Martins OkadaFaculdade de Medicina, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.
Gerson FerrariUniversidad de Santiago de Chile (USACH), Escuela de Ciencias de La Actividad Física, El Deporte y La Salud, Santiago, Chile.
Hongmei ZengNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Alessandro BigoniSão Paulo School of Business Administration, Getúlio Vargas Foundation, São Paulo, SP, Brazil.
Maria Paula CuradoEpidemiology and Statistics on Cancer Group, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
Catarina M AzeredoFaculdade de Medicina, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.
Leandro F M RezendeDepartment of Preventive Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiovascular disease (CVD) and cancer are the first and second leading causes of death in Brazil and worldwide. However, an ongoing epidemiological transition in which cancer surpasses CVD has been observed in many high and middle-income countries. In this study, we provided a nationwide analysis of the transition towards cancer mortality predominance over CVD mortality in Brazil. Methods: We leveraged data from 5570 municipalities using the Mortality Information System and classified the causes of death using ICD-10 codes. Age-standardized CVD and cancer mortality rates were calculated annually between 2000 and 2019. Mortality rate ratios (MRRs = CVD rates divided by cancer rates) described the predominance of cancer or CVD mortality across municipalities and states. Choropleth maps displayed state-specific MRRs and the transition in the predominant cause of death over time. Findings: From 2000 to 2019, CVD mortality rates declined in 25 out of 27 states, whereas cancer mortality increased in 15 states, indicating a shift towards cancer predominance. While in 2000 cancer mortality was lower than CVD in all states and only exceeded the latter in 7% of the municipalities, by 2019 the gap narrowed considerably, with 13% of municipalities displaying higher cancer mortality rates vs CVD mortality rates. Additionally, higher household income correlated with higher mortality from cancer vs CVD. Interpretation: An ongoing epidemiological transition in which cancer mortality surpasses CVD mortality is occurring in Brazil, particularly in municipalities with higher household incomes. Our findings may provide important information for policymakers and public health practitioners in Brazil. Funding: National Council for Scientific and Technological Development (CNPq).

Indexed as

BrazilCancerCardiovascular diseasesEpidemiolocal transition

Identifiers

PMID39430885
PMCPMC11489041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.